Correlation Between Century Therapeutics and Anika Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Anika Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Anika Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Anika Therapeutics, you can compare the effects of market volatilities on Century Therapeutics and Anika Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Anika Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Anika Therapeutics.

Diversification Opportunities for Century Therapeutics and Anika Therapeutics

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Century and Anika is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Anika Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anika Therapeutics and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Anika Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anika Therapeutics has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Anika Therapeutics go up and down completely randomly.

Pair Corralation between Century Therapeutics and Anika Therapeutics

Given the investment horizon of 90 days Century Therapeutics is expected to generate 2.19 times more return on investment than Anika Therapeutics. However, Century Therapeutics is 2.19 times more volatile than Anika Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Anika Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  341.00  in Century Therapeutics on August 31, 2024 and sell it today you would lose (169.00) from holding Century Therapeutics or give up 49.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  Anika Therapeutics

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Century Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Century Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Anika Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Century Therapeutics and Anika Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and Anika Therapeutics

The main advantage of trading using opposite Century Therapeutics and Anika Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Anika Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anika Therapeutics will offset losses from the drop in Anika Therapeutics' long position.
The idea behind Century Therapeutics and Anika Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets